TWD 16.9
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.07 Billion TWD | -4.77% |
2022 | 2.18 Billion TWD | -10.58% |
2021 | 2.44 Billion TWD | 8.0% |
2020 | 2.26 Billion TWD | 16.09% |
2019 | 1.94 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 2.18 Billion TWD | 5.21% |
2024 Q2 | 2.18 Billion TWD | 0.0% |
2023 Q3 | 2.07 Billion TWD | -6.17% |
2023 FY | 2.07 Billion TWD | -4.77% |
2023 Q1 | 2.21 Billion TWD | 1.49% |
2023 Q2 | 2.21 Billion TWD | 0.0% |
2023 Q4 | 2.07 Billion TWD | 0.0% |
2022 Q4 | 2.18 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -76.872% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -71.275% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 78.948% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 82.275% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 80.772% |
Center Laboratories, Inc. | 27 Billion TWD | 92.301% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -217.858% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 18.878% |
InnoPharmax Inc. | 524.19 Million TWD | -296.589% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -4.313% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -31.799% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -14.689% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -11.682% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 31.552% |
UniPharma Co., Ltd. | 350.07 Million TWD | -493.847% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 6.296% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -113.614% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -159.287% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -374.554% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -283.104% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -48.508% |